UPDATE 1 — Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
(Updates sourcing, adds details throughout) Oct 13 (Reuters) — Zealand Pharma and Generate Biomedicines said on Tuesday they have partnered to develop protein-based treatments for obesity and other metabolic diseases using AI, in a deal worth up to nearly $1.2 billion. Shares of Somerville, Massachusetts-based Generate